Combining genetic insight with baseline metabolic testingglucose, insulin, inflammatory markers, and lipid statuscreates a personalized framework your provider can use to design semaglutide duration strategy aligned with your individual physiology rather than population averages
Tirzepatide, a dual GLP-1 / glucose-dependent insulinotropic polypeptide (GIP) agonist, was superior to semaglutide in reducing HbA 1c and body weight in the SURPASS-2 trial, a phase 3, randomised, open-label trial comparing the efficacy and safety of tirzepatide vs semaglutide once weekly as add-on therapy to metformin in individuals with type 2 diabetes [10]
but heres the kicker, theyre critical for ensuring the medication works optimally for your condition
What Are GLP-1s
Protection from DHT Damage While GHK-Cu is not a DHT (dihydrotestosterone) blocker in itself, studies indicate that it may reduce the sensitivity of hair follicles to DHT , the hormone primarily responsible for androgenetic alopecia (pattern baldness)